Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics N.V (PRQR) Revenue: 2021-2025

Historic Revenue for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $3.4 million.

  • ProQR Therapeutics N.V's Revenue fell 20.17% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year decrease of 12.03%. This contributed to the annual value of $20.2 million for FY2024, which is 186.70% up from last year.
  • Per ProQR Therapeutics N.V's latest filing, its Revenue stood at $3.4 million for Q3 2025, which was down 22.02% from $4.3 million recorded in Q2 2025.
  • Over the past 5 years, ProQR Therapeutics N.V's Revenue peaked at $6.8 million during Q2 2024, and registered a low of $170,079 during Q1 2021.
  • Moreover, its 3-year median value for Revenue was $4.2 million (2024), whereas its average is $3.6 million.
  • As far as peak fluctuations go, ProQR Therapeutics N.V's Revenue spiked by 645.68% in 2022, and later plummeted by 44.57% in 2023.
  • Over the past 5 years, ProQR Therapeutics N.V's Revenue (Quarterly) stood at $273,409 in 2021, then spiked by 168.67% to $734,578 in 2022, then surged by 381.01% to $3.5 million in 2023, then spiked by 30.26% to $4.6 million in 2024, then fell by 20.17% to $3.4 million in 2025.
  • Its last three reported values are $3.4 million in Q3 2025, $4.3 million for Q2 2025, and $4.8 million during Q1 2025.